Annual Accounts Receivable
$0.00
-$5.56 M-100.00%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual accounts receivable is $0.00, with the most recent change of -$5.56 million (-100.00%) on December 31, 2023.
- During the last 3 years, SABS annual accounts receivable has fallen by -$20.57 million (-100.00%).
- SABS annual accounts receivable is now -100.00% below its all-time high of $20.57 million, reached on December 31, 2020.
Performance
SABS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- SABS quarterly accounts receivable is not available.
Performance
SABS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SABS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | - |
| 3 y3 years | -100.0% | - |
| 5 y5 years | -100.0% | - |
SABS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||
| 5 y | 5-year | -100.0% | at low | ||
| alltime | all time | -100.0% | at low |
SAB Biotherapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(-100.0%) |
| Jun 2023 | - | $364.10 K(-52.3%) |
| Mar 2023 | - | $763.10 K(-86.3%) |
| Dec 2022 | $5.56 M | $5.56 M(-57.1%) |
| Sep 2022 | - | $12.94 M(+34.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $9.61 M(-18.4%) |
| Mar 2022 | - | $11.79 M(+47.1%) |
| Dec 2021 | $8.01 M(-61.1%) | $8.01 M(-53.2%) |
| Jun 2021 | - | $17.11 M(-16.8%) |
| Dec 2020 | $20.57 M(+629.8%) | $20.57 M |
| Dec 2019 | $2.82 M | - |
FAQ
- What is SAB Biotherapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual accounts receivable year-on-year change?
- What is the all time high quarterly accounts receivable for SAB Biotherapeutics?
What is SAB Biotherapeutics annual accounts receivable?
The current annual accounts receivable of SABS is $0.00
What is the all time high annual accounts receivable for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual accounts receivable is $20.57 M
What is SAB Biotherapeutics annual accounts receivable year-on-year change?
Over the past year, SABS annual accounts receivable has changed by -$5.56 M (-100.00%)
What is the all time high quarterly accounts receivable for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly accounts receivable is $20.57 M